Bioequivalency Study of Anastrozole 1 mg Under Fed Conditions
Completed · Not applicable
Conditions studied: Breast Cancer
In brief
The objective of this study was to prove the bioequivalence of Anastrozole Tablet under fed conditions
Key facts
- Study ID
- NCT01155089
- Run by
- Roxane Laboratories
- People needed
- 32
- Starts
- 2006-05-01
- Expected to finish
- 2006-06-01
- Last updated by the study team
- 2018-01-23
Who can join
Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- No clinically significant abnormal findings on the physical examination, medical history, or clinical laboratory results during screening
You may not qualify if…
- Positive test for HIV, Hepatitis B, or Hepatitis C.
- Treatment with known enzyme altering drugs.
- History of allergic or adverse response to anastrozole or any comparable or similar product.
Where it is running
- Bio-Kinetic Clinical Applications — Springfield, Missouri, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.